论文信息 - Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 - 字舞流文

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19

A. Al-Sabi | T. A. Abd El-Aziz | J. Stockand

[1] Arthur S Slutsky,et al. Human recombinant soluble ACE2 in severe COVID-19 , 2020, The Lancet Respiratory Medicine.

[2] Martin Stahl,et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.

[3] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[4] S. Krähenbühl,et al. Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects , 2013, Clinical Pharmacokinetics.

[5] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.